Hiroshi Miyake
Founder at CHORDIA THERAPEUTICS INC.
Net worth: 9 $ as of 29/04/2024
Profile
Hiroshi Miyake is the founder and current Chief Executive Officer & Representative Director of Chordia Therapeutics, Inc. which is founded in 2017.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 09/05/2024 | 900,000 ( 1.37% ) | 9 $ | 29/04/2024 |
Hiroshi Miyake active positions
| Companies | Position | Start |
|---|---|---|
| CHORDIA THERAPEUTICS INC. | Founder | 11/10/2017 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Chordia Therapeutics, Inc.
 Chordia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chordia Therapeutics, Inc. engages in the research and development of novel therapies for cancers. It handles research and development of low-molecular-weight drugs with unprecedented new mechanisms of action in the oncology area. The company was founded by Hiroshi Miyake and Daisuke Morishita on October 12, 2017 and is headquartered in Fujisawa, Japan. | Health Technology |
- Stock Market
- Insiders
- Hiroshi Miyake